What Businesses Should Start Thinking About Now?

The UAE is preparing to introduce an R&D Tax Credit under its federal corporate tax framework, a move that signals serious intent to strengthen the country’s innovation ecosystem.

For businesses investing in technology, product development, AI, biotech, advanced manufacturing, or digital platforms, this could become one of the most meaningful funding opportunities available.

But the real opportunity is not in 2027 when claims are filed.
It is in 2026 when the work happens.

What is the UAE R&D Tax Credit?

The proposed regime will operate as an expenditure-based tax credit, allowing eligible companies to claim 30%–50% of qualifying R&D costs.

Importantly:

• It is expected to be refundable in many cases meaning businesses may receive cash back even if they have limited or no tax liability
• It is expected to apply to both mainland and free zone entities, including those operating under 0% corporate tax regimes

For startups and innovation-led companies, this transforms R&D from a pure cost centre into a potentially recoverable investment.

When does it apply?

• Financial years beginning on or after 1 January 2026
• First claims likely to be filed in 2027

That gives businesses a preparation window, but not a long one.

R&D incentives are won or lost in how activities are documented during the year not at the time of filing.

What will qualify as R&D?

The UAE intends to align eligibility with the OECD Frascati Manual framework, which focuses on:

• Scientific or technological uncertainty
• Advancement beyond routine improvements
• Systematic experimentation and evidence-based development

Routine upgrades, aesthetic changes, standard market research, or quality control testing are unlikely to qualify.

In short genuine innovation is rewarded. Routine business activity is not.

Why this matters commercially

A 30%–50% credit on eligible expenditure can materially change cash flow dynamics.

Qualifying costs may include:

• R&D staff costs
• Subcontractor expenses
• Materials and consumables
• Software, cloud and data costs

If refundable, the benefit is not just a tax reduction, it can be a direct cash injection.

For growing businesses, that can mean:

• Extended runway
• Reduced reliance on equity dilution
• Accelerated product development

The real challenge: Documentation

This is where many companies struggle globally.

To defend a claim, businesses will need:

• Technical project documentation
• Clear cost tracking
• R&D time allocation records
• Evidence of experimentation and testing
• Proof activities were conducted in the UAE

Waiting until filing season often leads to incomplete documentation, missed qualifying costs, and higher audit risk.

Who should be preparing now?

• Startups and SMEs investing heavily in development
• AI, tech, biotech, and advanced manufacturing businesses
• Free zone innovation hubs
• Multinationals setting up regional R&D centres

If innovation is part of your strategy, this incentive is relevant.

Why 2026 preparation is critical?

Eligibility will depend entirely on how projects are structured and tracked during 2026.

Businesses that prepare early can:

• Capture maximum qualifying costs
• Implement defensible tracking systems
• Reduce audit exposure
• Submit a stronger first claim in 2027

Those that wait may simply leave money on the table.

How Dhruva Can Support R&D Readiness?

Becoming “R&D ready” before the regime goes live is the most effective way to maximise benefit while remaining compliant.

Dhruva can assist with:

• Assessing project-level eligibility
• Designing real-time cost tracking systems
• Preparing technical documentation
• Aligning activities with OECD standards
• Managing end-to-end claim submission

The goal is simple: help businesses unlock available incentives confidently and defensibly.

If your business is investing in innovation, now is the time to start structuring for it.

The regime is expected to apply from 2026, with further guidance to be issued by the Ministry of Finance. The final form and implementation remain subject to legislative approval.

But preparation does not need to wait.

Please reach out to Farid Jumah at farid.jumah@dhruvaadvisors.com if you’d like to explore your R&D eligibility or readiness.